Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for ZBH
-1.87 (-1.48%)
Real-time:   3:03PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 124.34 - 125.95
52 week 108.03 - 133.49
Open 125.65
Vol / Avg. 693,491.00/1.46M
Mkt cap 25.18B
P/E 38.78
Div/yield 0.24/0.77
EPS 3.21
Shares 202.47M
Beta 1.15
Inst. own 88%
Jan 30, 2018
Q4 2017 Zimmer Biomet Holdings Inc Earnings Call - 8:00AM EST - Add to calendar
Jan 30, 2018
Q4 2017 Zimmer Biomet Holdings Inc Earnings Release - 7:00AM EST - Add to calendar
Jan 9, 2018
Zimmer Biomet Holdings Inc at JPMorgan Healthcare Conference - Webcast
Nov 28, 2017
Zimmer Biomet Holdings Inc at Piper Jaffray Healthcare Conference - Webcast
Nov 16, 2017
Zimmer Biomet Holdings Inc at Jefferies Global Healthcare Conference - Webcast
Nov 1, 2017
Q3 2017 Zimmer Biomet Holdings Inc Earnings Call - Webcast
Nov 1, 2017
Q3 2017 Zimmer Biomet Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 5.43% 3.96%
Operating margin 11.74% 10.75%
EBITD margin - 32.24%
Return on average assets 1.50% 1.13%
Return on average equity 3.82% 3.13%
Employees 18,500 -
CDP Score - D


345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.

Officers and directors

Bryan C. Hanson President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Robert D. Delps President, Americas
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D. Ph.D. President, Europe, Middle East and Africa
Age: 52
Bio & Compensation  - Reuters
Sang Yi President, Asia Pacific
Age: 54
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Larry C. Glasscock Independent Non-Executive Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Christopher B. Begley Independent Director
Age: 65
Bio & Compensation  - Reuters
Betsy J. Bernard Independent Director
Age: 61
Bio & Compensation  - Reuters
Gail Koziara Boudreaux Independent Director
Age: 56
Bio & Compensation  - Reuters